Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Working together against Alzheimer‘s, Parkinson‘s and dementia

10.12.2012
Two institutions of the Helmholtz Association are joining forces for health research: How does the brain protect itself from pathogens? Can infections favour Alzheimer’s disease? Scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Helmholtz Centre for Infection Research (HZI) in Braunschweig want to tackle such questions together over the next few years. The interdisciplinary collaboration will receive funding of approximately 600,000 Euro. The researchers hope to discover new facts about dementia and other brain diseases.
Joint press release DZNE / HZI

“Despite a number of studies in the past we do not yet know what the role of infections is in favouring neurodegenerative disease progression,“ says the Scientific Director of the DZNE, Prof. Pierluigi Nicotera. “Chronic inflammations due to pathogens may favour certain processes in the brain that ultimately may cause neuronal damage.”

Prof. Dirk Heinz, Scientific Director of the HZI, points to the potential of this joint venture: “Despite common interests there has as yet been too little exchange between neurobiologists and infection researchers. We want to change this,” says Heinz. “This collaboration offers the best prospects as the expertise and methodology of both Helmholtz Centres complement each other optimally. We want to use this synergy and such interlinking is fully in line with the philosophy of the Helmholtz Association.”

Joint projects

The Helmholtz Centres will collaborate on two projects over the next three years. Each receives funding of around 300,000 Euro. The laboratory studies are intended to explore fundamental issues related to infection processes and neurobiology.

One of the research projects will investigate the assumption that repeated infections may promote neurodegenerative diseases, in particular Alzheimer’s disease. Prof. Michael Heneka from the DZNE and Prof. Martin Korte from the HZI will collaborate on this. The second project will tackle the role of certain brain cells, so-called astrocytes, in fighting off viral infections. This subject will be investigated jointly by Prof. Frank Bradke (DZNE), Prof. Ulrich Kalinke (HZI) and Prof. Martin Stangel from the Hannover Medical School.

The German Center for Neurodegenerative Diseases (DZNE) investigates the causes of diseases of the nervous system and develops strategies for prevention, treatment and care. It is a member of the Helmholtz Association and has sites in Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen and Witten. The administrative headquarters are in Bonn. The DZNE cooperates closely with universities, their clinics and other research facilities. Website: http://www.dzne.de/en

At the Helmholtz Centre for Infection Research, scientists study microbial virulence factors, host-pathogen interactions and immunity. The goal is to develop strategies for the diagnosis, prevention and therapy of human infectious diseases. The head office is in Braunschweig with branches in Hannover and Saarbrücken. Website: http://www.helmholtz-hzi.de/en

Dr. Marcus Neitzert | idw
Further information:
http://www.helmholtz-hzi.de/en
http://www.dzne.de/en
http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-30.html

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>